Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions
Debra Weinstat‐Saslow(National Cancer Institute), Patricia S. Steeg(National Cancer Institute), Karl D. Wittenbel(Vanderbilt University), Jean F. Simpson(Good Samaritan Hospital), Richard E. Manrow(National Cancer Institute), Julia Lawrence(National Cancer Institute), Maria J. Merino(National Institutes of Health), David L. Page(Duke University), Ray F. Bluth(Vanderbilt University)
Cited by 339
Related Papers
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
|New England Journal of Medicine|1985|1.9k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Prognostic Factors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2000|1.1k
Myocardial Changes Associated with Cardiogenic Shock
|New England Journal of Medicine|1971|677